Fragment Rule of Three (Ro3) Descriptors and Lead-Likeness
Read the descriptors of low-molecular-weight chemical structures against the fragment-based discovery Rule of Three (Ro3) guidelines: molecular weight below 300 Da, Crippen logP at or below 3, hydrogen-bond donors at or below 3, acceptors at or below 3 and rotatable bonds at or below 3. The workbench shows each descriptor but does not apply these limits or mark a pass or fail; you compare the values yourself. The workspace opens paracetamol (acetaminophen) as a compact fragment-sized reference.
Uses the shipped ChEMBL 37 paracetamol structure (CHEMBL112, MW 151.2 g/mol, 11 heavy atoms), providing a concrete small-molecule reference inside the classical fragment molecular-weight and polarity regime.
Preserve physicochemical headroom for fragment growing and linking
When a high-throughput screening hit enters medicinal-chemistry optimisation with a molecular weight of 480 g/mol and a cLogP of 4.6, almost any substituent added to improve potency or metabolic stability pushes the series outside favourable solubility and clearance bounds. Fragment-based drug discovery inverts that trajectory by identifying small, polar, low-complexity motifs (10 to 20 heavy atoms) that bind a sub-pocket with high per-atom efficiency.
Inspecting a compact reference like paracetamol in the workspace highlights how few rotatable bonds and polar atoms are needed to establish a directional hydrogen-bonding network while keeping molecular weight near 150 Da.
Combine heavy-atom counts with biophysical binding evidence
Use the heavy-atom count, ring count, Fsp3 and TPSA descriptors from the workbench alongside experimental Kd or IC50 values to monitor whether each synthetic elaboration step maintains ligand efficiency and lipophilic ligand efficiency rather than gaining potency purely through non-specific hydrophobic bulk.
Equations and variables
Congreve Rule of Three (Ro3) fragment criteria
MW < 300; cLogP ≤ 3; HBD ≤ 3; HBA ≤ 3; (often Nrot ≤ 3 and TPSA ≤ 60 Ų)
- MW
- Average molecular weight of the neutral fragment structure (g/mol)
- cLogP
- Computed neutral-species octanol–water partition estimate
- HBD, HBA
- Hydrogen-bond donor and acceptor counts under the stated engine definition
- Nrot
- Strict rotatable-bond count
Ligand efficiency from binding free energy or potency
LE = −ΔG / Nheavy ≈ (1.3642 × pIC50) / Nheavy
- LE
- Binding energy per non-hydrogen heavy atom at 298.15 K, where 1.3642 = ln 10 × R × T in kcal/mol (R = 1.9872 cal mol⁻¹ K⁻¹) (kcal mol⁻¹ atom⁻¹)
- pIC50
- Negative base-10 logarithm of molar IC50 or Kd
- Nheavy
- Count of non-hydrogen heavy atoms in the represented ligand
Scope and limitations
- A small molecule that satisfies Rule of Three thresholds is not automatically a high-quality screening fragment; aqueous solubility at high millimolar concentrations, chemical stability and synthetic growth vectors must be verified.
- Ligand efficiency uses a logarithmic potency term divided by heavy-atom count and assumes that IC50 approximates an equilibrium dissociation constant under the assay conditions.
- Growing or linking two low-affinity fragments into a clinical candidate typically increases molecular weight and lipophilicity, which is why starting well below Lipinski limits preserves room for optimisation.
Sources and provenance
- RDKit descriptor implementation and versioned reference checksBSD-3-Clause
Method implementation; computed molecular properties are estimates.
- ChEMBL 37 parent structures in the shipped compound libraryCC BY-SA 3.0; share-alike
Existing library capture: 28 September 2026. Preserve attribution when redistributing its rows.
- Wildman and Crippen: atomic contributions to molecular propertiesCited method; no reproduced article data
- Ertl, Rohde and Selzer: fast calculation of molecular polar surface areaCited method; no reproduced article data
- Congreve et al.: a Rule of Three for fragment-based lead discovery?Cited method; Rule of Three fragment guidelines
- Hopkins, Groom and Alex: ligand efficiency: a useful metric for lead selectionCited method; heavy-atom ligand efficiency metric
Technical questions
Why start a hit-to-lead campaign with fragments under 300 Da instead of 450 Da drug-like hits?
Combinatorial chemical space for 11 to 18 heavy atoms is vastly smaller than for 35 heavy atoms, so a compact library of a few thousand low-complexity fragments samples binding motifs efficiently without steric clashes. Moreover, medicinal-chemistry optimisation almost always adds mass and logP, so starting small avoids molecular obesity.
Why do fragments require biophysical assays or high millimolar biochemical screening concentrations?
Because a fragment forms only a few high-quality interactions with a protein pocket, its equilibrium dissociation constant typically lies in the 50 µM to 5 mM range. Detecting that weak binding reliably requires high aqueous solubility and biophysical methods such as NMR, SPR, X-ray crystallography or thermal shift.
How do donor and acceptor definitions affect a Rule of Three comparison?
Just as in Lipinski calculations, historical nitrogen-plus-oxygen atom counts can differ slightly from functional-group acceptor site counts. For small fragments with one or two polar rings, inspect the exact HBD and HBA numbers directly in the descriptor table.
Connected workflows
- Lipinski rule-of-five property inspection
Compare compact fragment Ro3 bounds with full-sized oral drug Lipinski thresholds.
- 4PL IC50 curve fitting
Evaluate high-concentration dose-response curves and plateau coverage limits.
- DMSO stock reconstitution volume
Plan concentrated millimolar DMSO stocks required for biophysical fragment screens.